M.F. Beal
Beal, M. Flint.
Beal, M. Flint, 19..-....
Beal, M. Flint, 1950-
VIAF ID: 76565427 (Personal)
Permalink: http://viaf.org/viaf/76565427
Preferred Forms
- 200 _ | ‡a Beal ‡b M. Flint
-
- 100 1 _ ‡a Beal, M. Flint
- 100 1 0 ‡a Beal, M. Flint
- 100 1 _ ‡a Beal, M. Flint
-
-
-
-
-
- 100 1 _ ‡a Beal, M. Flint ‡d 1950-
- 100 1 _ ‡a Beal, M. Flint, ‡d 19..-....
-
-
- 100 0 _ ‡a M.F. Beal
4xx's: Alternate Name Forms (7)
Works
Title | Sources |
---|---|
CNS neuroprotection | |
The Dana guide to brain health | |
Excitotoxicity in neurological diseases : new therapeutic challenge | |
An in vivo model for the neurodegenerative effects of beta amyloid and protection by substance P | |
In vivo neurotoxicity of beta-amyloid [beta(1-40)] and the beta(25-35) fragment | |
Increased 3-nitrotyrosine and oxidative damage in mice with a human copper/zinc superoxide dismutase mutation. | |
Increased 3-nitrotyrosine in brains of Apo E-deficient mice | |
Increased levels of plasma cholesteryl ester hydroperoxides in patients with subarachnoid hemorrhage | |
Increased plaque burden in brains of APP mutant MnSOD heterozygous knockout mice. | |
Increased plasma levels of matrix metalloproteinase-9 in patients with Alzheimer's disease. | |
Increased survival and neuroprotective effects of BN82451 in a transgenic mouse model of Huntington's disease. | |
Increases in cortical glutamate concentrations in transgenic amyotrophic lateral sclerosis mice are attenuated by creatine supplementation. | |
Inhibition of neuronal nitric oxide synthase protects against MPTP toxicity | |
Inhibition of the leucine-rich repeat protein LINGO-1 enhances survival, structure, and function of dopaminergic neurons in Parkinson's disease models | |
Inosine to increase serum and cerebrospinal fluid urate in Parkinson disease: a randomized clinical trial | |
Integrative role of cPLA with COX-2 and the effect of non-steriodal anti-inflammatory drugs in a transgenic mouse model of amyotrophic lateral sclerosis | |
Intraneuronal Alzheimer abeta42 accumulates in multivesicular bodies and is associated with synaptic pathology | |
Involvement of free radicals in excitotoxicity in vivo. | |
Kynurenic acid concentrations are reduced in Huntington's disease cerebral cortex | |
Lack of exacerbation of neurodegeneration in a double transgenic mouse model of mutant LRRK2 and tau. | |
Large stem cell grafts could lead to erroneous interpretations of behavioral results? | |
Less stress, longer life | |
Leucine-rich repeat kinase 2: a new player with a familiar theme for Parkinson's disease pathogenesis | |
Limited-time exposure to mitochondrial toxins may lead to chronic progressive neurodegenerative diseases | |
Loss of Fas ligand-function improves survival in G93A-transgenic ALS mice | |
Lymphocyte oxidative DNA damage and plasma antioxidants in Alzheimer disease. | |
Malonate and 3-nitropropionic acid neurotoxicity are reduced in transgenic mice expressing a caspase-1 dominant-negative mutant. | |
Malonate produces striatal lesions by indirect NMDA receptor activation. | |
Manganese intoxication in the rhesus monkey: a clinical, imaging, pathologic, and biochemical study | |
Manganese porphyrin given at symptom onset markedly extends survival of ALS mice | |
Manganese superoxide dismutase overexpression attenuates MPTP toxicity. | |
Matrix metalloproteinase-3: a novel signaling proteinase from apoptotic neuronal cells that activates microglia. | |
Matrix metalloproteinase-9 is elevated in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice | |
Matrix metalloproteinase-9 regulates TNF-alpha and FasL expression in neuronal, glial cells and its absence extends life in a transgenic mouse model of amyotrophic lateral sclerosis | |
Measurement of kynurenic acid in mammalian brain extracts and cerebrospinal fluid by high-performance liquid chromatography with fluorometric and coulometric electrode array detection | |
Measuring the effects of therapy in Parkinson disease | |
Mechanisms of reduced striatal NMDA excitotoxicity in type I nitric oxide synthase knock-out mice. | |
Merging mitochondria for neuronal survival | |
Metabolomic analysis and signatures in motor neuron disease | |
Metabolomic profiling to develop blood biomarkers for Parkinson's disease | |
Methylene blue upregulates Nrf2/ARE genes and prevents tau-related neurotoxicity | |
Mice deficient in cellular glutathione peroxidase show increased vulnerability to malonate, 3-nitropropionic acid, and 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine | |
Mice deficient in group IV cytosolic phospholipase A2 are resistant to MPTP neurotoxicity. | |
Mice lacking alpha-synuclein are resistant to mitochondrial toxins | |
Mice overexpressing 70-kDa heat shock protein show increased resistance to malonate and 3-nitropropionic acid | |
MicroRNA-related cofilin abnormality in Alzheimer's disease | |
Minocycline enhances MPTP toxicity to dopaminergic neurons | |
Mitochondria targeted peptides protect against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity | |
Mitochondria targeted therapeutic approaches in Parkinson's and Huntington's diseases | |
Mitochondrial aconitase is a transglutaminase 2 substrate: transglutamination is a probable mechanism contributing to high-molecular-weight aggregates of aconitase and loss of aconitase activity in Huntington disease brain | |
Mitochondrial alpha-ketoglutarate dehydrogenase complex generates reactive oxygen species. | |
Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis | |
Mitochondrial dihydrolipoyl succinyltransferase deficiency accelerates amyloid pathology and memory deficit in a transgenic mouse model of amyloid deposition | |
Mitochondrial DNA 4977 bp deletion and OH8dG levels correlate in the brain of aged subjects but not Alzheimer's disease patients. | |
Mitochondrial dysfunction and oxidative damage in neurodegenerative diseases, c1995: | |
Neorodegenerative diseases / M. Flint Beal, Anthony E. Lang and Albert C. Ludolph. - Cambridge, 2005. | |
Neurodegenerative diseases : neurobiology, pathogenesis, and therapeutics | |
A neuroprotective role of the human uncoupling protein 2 (hUCP2) in a Drosophila Parkinson's disease model. | |
A novel systemically active caspase inhibitor attenuates the toxicities of MPTP, malonate, and 3NP in vivo | |
Principi interne medicine | |
Unexpected lack of hypersensitivity in LRRK2 knock-out mice to MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine). |